Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin

Jean A. Hamilton, Larry K. Steinrauf, Juris Liepnieks, Merrill Benson, Gosta Holmgren, Olan Sandgren, Lars Steen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The structure of a variant transthyretin has been determined by X-ray crystallography at 2.3 Å resolution in order to investigate those changes which lead to amyloid formation. This variant transthyretin, in which the internal valyl residue at position 30 is replaced by methionyl, is associated with the most common form of familial amyloidotic polyneuropathy (FAP). Comparison to the known structure of the normal transthyretin tetramer shows that the bulkier methionine residue 30 which lies between the nearly orthogonal beta sheets of the dimer, results in the sheets being displaced an average of 0.4 Å. The internal structure of the sheets and of the monomer-monomer interface is maintained. Such global changes may affect the metabolic properties and the tendency towards polymerization of the mutant protein. These findings may form a basis for understanding other amyloid-deposition diseases.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1139
Issue number1-2
DOIs
StatePublished - Jun 9 1992

Fingerprint

Prealbumin
Molecular Structure
Amyloid
Polyneuropathies
X Ray Crystallography
Mutant Proteins
Polymerization
Methionine

Keywords

  • Beta-sheet protein
  • Familial amyloidosis
  • Met-30 transthyretin variant
  • X-ray crystal structure

ASJC Scopus subject areas

  • Biophysics
  • Molecular Biology
  • Molecular Medicine

Cite this

Alteration in molecular structure which results in disease : the Met-30 variant of human plasma transthyretin. / Hamilton, Jean A.; Steinrauf, Larry K.; Liepnieks, Juris; Benson, Merrill; Holmgren, Gosta; Sandgren, Olan; Steen, Lars.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1139, No. 1-2, 09.06.1992, p. 9-16.

Research output: Contribution to journalArticle

Hamilton, Jean A. ; Steinrauf, Larry K. ; Liepnieks, Juris ; Benson, Merrill ; Holmgren, Gosta ; Sandgren, Olan ; Steen, Lars. / Alteration in molecular structure which results in disease : the Met-30 variant of human plasma transthyretin. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1992 ; Vol. 1139, No. 1-2. pp. 9-16.
@article{0e2e4f5939a840b0a8401264862583b7,
title = "Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin",
abstract = "The structure of a variant transthyretin has been determined by X-ray crystallography at 2.3 {\AA} resolution in order to investigate those changes which lead to amyloid formation. This variant transthyretin, in which the internal valyl residue at position 30 is replaced by methionyl, is associated with the most common form of familial amyloidotic polyneuropathy (FAP). Comparison to the known structure of the normal transthyretin tetramer shows that the bulkier methionine residue 30 which lies between the nearly orthogonal beta sheets of the dimer, results in the sheets being displaced an average of 0.4 {\AA}. The internal structure of the sheets and of the monomer-monomer interface is maintained. Such global changes may affect the metabolic properties and the tendency towards polymerization of the mutant protein. These findings may form a basis for understanding other amyloid-deposition diseases.",
keywords = "Beta-sheet protein, Familial amyloidosis, Met-30 transthyretin variant, X-ray crystal structure",
author = "Hamilton, {Jean A.} and Steinrauf, {Larry K.} and Juris Liepnieks and Merrill Benson and Gosta Holmgren and Olan Sandgren and Lars Steen",
year = "1992",
month = "6",
day = "9",
doi = "10.1016/0925-4439(92)90075-X",
language = "English",
volume = "1139",
pages = "9--16",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Alteration in molecular structure which results in disease

T2 - the Met-30 variant of human plasma transthyretin

AU - Hamilton, Jean A.

AU - Steinrauf, Larry K.

AU - Liepnieks, Juris

AU - Benson, Merrill

AU - Holmgren, Gosta

AU - Sandgren, Olan

AU - Steen, Lars

PY - 1992/6/9

Y1 - 1992/6/9

N2 - The structure of a variant transthyretin has been determined by X-ray crystallography at 2.3 Å resolution in order to investigate those changes which lead to amyloid formation. This variant transthyretin, in which the internal valyl residue at position 30 is replaced by methionyl, is associated with the most common form of familial amyloidotic polyneuropathy (FAP). Comparison to the known structure of the normal transthyretin tetramer shows that the bulkier methionine residue 30 which lies between the nearly orthogonal beta sheets of the dimer, results in the sheets being displaced an average of 0.4 Å. The internal structure of the sheets and of the monomer-monomer interface is maintained. Such global changes may affect the metabolic properties and the tendency towards polymerization of the mutant protein. These findings may form a basis for understanding other amyloid-deposition diseases.

AB - The structure of a variant transthyretin has been determined by X-ray crystallography at 2.3 Å resolution in order to investigate those changes which lead to amyloid formation. This variant transthyretin, in which the internal valyl residue at position 30 is replaced by methionyl, is associated with the most common form of familial amyloidotic polyneuropathy (FAP). Comparison to the known structure of the normal transthyretin tetramer shows that the bulkier methionine residue 30 which lies between the nearly orthogonal beta sheets of the dimer, results in the sheets being displaced an average of 0.4 Å. The internal structure of the sheets and of the monomer-monomer interface is maintained. Such global changes may affect the metabolic properties and the tendency towards polymerization of the mutant protein. These findings may form a basis for understanding other amyloid-deposition diseases.

KW - Beta-sheet protein

KW - Familial amyloidosis

KW - Met-30 transthyretin variant

KW - X-ray crystal structure

UR - http://www.scopus.com/inward/record.url?scp=0026697314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026697314&partnerID=8YFLogxK

U2 - 10.1016/0925-4439(92)90075-X

DO - 10.1016/0925-4439(92)90075-X

M3 - Article

C2 - 1610922

AN - SCOPUS:0026697314

VL - 1139

SP - 9

EP - 16

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1-2

ER -